For the first time in its history, the 73rd Annual Meeting of the American Academy of Neurology (AAN) – the world’s premier neurology meeting – was held in a fully virtual format from April 17th to 22nd 2021
Welcome to AAN 2021
James Stevens, AAN President
The 2021 virtual AAN annual meeting was centred around a rich educational and scientific programme including over 90 expert-led educational courses, more than 2000 scientific abstracts and seven key plenary sessions featuring leaders in neurology.
AAN President James Stevens, Fort Wayne, USA, began this key plenary session with presentation of the President’s Award followed by the Presidential Lecture entitled: ‘Disruption: How to Pivot from Uncertainty to Success - the AAN Story.’ Dr Stevens proposed a focused five-pronged approach to navigating crises such as COVID-19.
Five-pronged approach to navigating crises such as COVID-19.
“What a year it has been - unprecedented does not even begin to describe what we have all been through. We’ve faced uncertainty, exhaustion and challenge but we are emerging stronger, resilient and prepared to face our new future. ”
President James Stevens, Fort Wayne, USA
Orly Avitzur, AAN President-Elect
The 2021 virtual AAN annual meeting was centred around a rich educational and scientific programme including over 90 expert-led educational courses, more than 2000 scientific abstracts and seven key plenary sessions featuring leaders in neurology.
There then followed a brief welcome address by AAN President-Elect Orly Avitzur, Tarrytown, USA, who will be charged with leading the academy over the next two years. As we enter the recovery phase of the pandemic, Dr Avitzur outlined some exciting AAN programmes for the future including an increasing focus on hybrid educational and scientific meetings, studies to support telemedicine and an expanded emphasis on well-being.
STROKE
Controversies in Neurology
On the topic ‘Shattering the clock: should there be a time window for acute stroke intervention?’, Maarten Lansberg, Stanford, USA, advocated in favour of routine use of advanced imaging such as computed tomography (CT) perfusion scans in patients with stroke who present within the 6-hour time window. Adopting this approach in the acute setting can facilitate more accurate diagnosis, accelerated work-up and appropriate selection of patients for thrombolysis and thrombectomy, insisted Dr Lansberg, especially as the Alberta stroke programme early CT (ASPECT) score cannot be entirely relied on for visualisation of the ischaemic core. In response, Jeffrey Saver, Los Angeles, USA, argued that time matters greatly in the acute stroke setting, whereas imaging selection and imaging intra-guidance matter little. Convincing randomised clinical trial evidence shows better outcomes with a time-based versus tissue-based strategy under 6 hours. Patients with large vessel occlusion suspected acute stroke should therefore be transferred directly to the angiography suite and not sent to CT first, Dr Saver concluded.
Closing Remarks
Hailing this year’s annual meeting as ‘ANN excellence delivered unconventionally’ outgoing President Dr Stevens closed the congress by handing the reins of leadership to the new ANN President Dr Avitzur with the passing of the gavel. Dr Avitzur expressed her hope for an optimistic future with next year’s AAN meeting, due to take place in Seattle, Washington, between the 2nd and 8th April 2022, providing the opportunity for members to come back together again in person.
©Springer Healthcare 2021. This content has been independently selected and developed by Springer Healthcare and licensed by Roche for Medically. The topics covered are based on therapeutic areas specified by Roche. This content is not intended for use by healthcare professionals in the UK, US or Australia. Inclusion or exclusion of any product does not imply its use is either advocated or rejected. Use of trade names is for product identification only and does not imply endorsement. Opinions expressed do not reflect the views of Springer Healthcare. Springer Healthcare assumes no responsibility for any injury or damage to persons or property arising out of, or related to, any use of the material or to any errors or omissions. Please consult the latest prescribing information from the manufacturer for any products mentioned in this material.